NMR NMR
Company Profile ↓Company Overview
NMR (NMR) is a publicly traded company listed on with a market capitalization of $30.67B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 57.4% per year over the last five years.
Revenue has grown at a 17.2% CAGR over the past five years.
Trades at an undemanding P/E of 0.1.
Maintains a net profit margin of 19.7%.
Recent Developments
- Mar 2026 Revenue of $1.84T (+10.8% YoY); net profit $362.13B.
- Trailing 12 Months Year-on-year growth — revenue +10.8%, earnings +6.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 17.2%, profit CAGR 57.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 17.17% |
| 1 Year: | 10.80% |
Compounded Profit Growth
| 5 Years: | 57.44% |
| 1 Year: | 6.28% |
Stock Price Performance
| 1 Year: | +46.89% |
| 6 Months: | +15.06% |
| 3 Months: | +25.86% |
| 1 Month: | +5.41% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)62.83 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 17.2% over 5 years.
- Profit CAGR of 57.4% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 478.54B | 468.27B | 497.76B | 397.39B | 612.38B |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | 633.27B | 645.75B | 676.17B | 635.58B | 684.99B |
| Pretax Income | 160.28B | 136.65B | 135.22B | 107.67B | 211.54B |
| Tax Provision | 52.81B | 40.85B | 40.67B | 31.10B | 55.42B |
| Net Income | 104.56B | 92.08B | 91.55B | 73.93B | 145.56B |
| Diluted EPS | 34.04 | 30.49 | 30.19 | 24.34 | 48.34 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 1.14T | 1.38T | 1.66T | 1.84T |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 1.15T | 2.60T | 2.84T | 2.59T |
| Pretax Income | - | 149.47B | 273.85B | 471.96B | 539.82B |
| Tax Provision | - | 57.80B | 96.63B | 124.71B | 165.44B |
| Net Income | - | 92.79B | 165.86B | 340.74B | 362.13B |
| Diluted EPS | - | 29.74 | 52.69 | 111.03 | 118.99 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 47.77T | 55.15T | 56.80T | 62.65T |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 4.52T | 5.15T | 5.51T | 5.65T |
| Inventory | - | - | - | - | - |
| Receivables | - | 379.91B | 453.94B | 410.72B | 470.34B |
| Total Liabilities | - | 44.55T | 51.70T | 53.22T | 58.79T |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | 10.73T | 12.85T | 13.77T | 15.93T |
| Total Debt | - | 11.94T | 14.09T | 15.06T | 17.84T |
| Total Equity | - | 3.15T | 3.35T | 3.47T | 3.71T |
| Shares Outstanding | - | 3.23B | 3.16B | 3.16B | 3.09B |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -694.82B | 132.64B | -678.61B | -842.96B |
| Investing Cash Flow | - | -233.22B | -887.94B | -848.65B | -1.50T |
| Financing Cash Flow | - | 1.28T | 1.01T | 1.68T | 2.10T |
| Capital Expenditure | - | -171.16B | -145.78B | -189.97B | -353.82B |
| Free Cash Flow | - | -865.99B | -13.14B | -868.58B | -1.20T |
| Net Change in Cash | - | 355.89B | 257.55B | 152.44B | -246.03B |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 8.1% | 12.0% | 20.5% | 19.7% |
| ROE % | - | 2.9% | 5.0% | 9.8% | 9.8% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NMR
Understanding the Setup: (NMR) and Scalable Risk - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxQQ2ZXUHlucWthcENXaEdxZnRvTjNnSWw5TDBtVkp4Tm15XzZtdkdlXzlwLWl2SHZEaVE0UkRqUXZKekZpNUpsaW9xZ2ZabTJmY3ZRbGlRY3JnRUpiSEdaeEFDeFFUWGo5djRvd1FjemNqQUt1LWktcHcyMTdLZ3NsUDYwN0dXbFNjM0xCVU…
Is Nomura (NMR) Stock Undervalued Right Now? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOQUZ2c3BqS0JKUzd4UGJqcE5faWdrbkIxdVZWY0loU3RPb2k5ekRQQWdHdndUVEUwZW02LWVpVGpxUUN4R0l1QVhlSmtZQ3psV2o1MW1KbVpLMXBTZ2pXanhnNE12c283Rk1ZaER2Um16aDhhLWU5bm9Cb3d5TWJzZjRIek9idlk2YWl0QU…
Nomura Holdings Inc ADR (NYSE:NMR) Given Consensus Rating of "Buy" by Analysts - MarketBeat
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPejVNWjN5Yml6TXNxWWNXdjg4R1RVNER1MDZqVHNxZ3pWSzFBekJpaHRCbG1wbzFCbnpQM1BCLW1VWE43eGEyNTdTLS1vd3JwMnlDeXh2MGRMS0JDZDM0S2FDRm1YSkY0OThtS0ZINnRXazRmRS1Fa211bUpCaE93eWJEYUpaY1c2dUxTOE…
NMR or JPM: Which Is the Better Value Stock Right Now? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxOb1lfSXRMcUFuV3pIaldSWWM5U3FOX1ZadEJVOHdyXzFPam0yRkdMVVFTeTk1cTIteEVldUtHLUV1QVZHYzliQnVLNU9sVEJEaTFCZzdBazFjS3l2WFphUF9TU1paNzNkOTBmaGNoa2MtRnBJaEZQYWhsejh1ZGthNXhRS2FlM3Jia3FLRk…
Nomura Holdings (NYSE: NMR) executive gets 245-share award, updates direct and plan holdings - Stock Titan
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxNcGFhT3dyd1VkZGUtUm5PemR0Umh3RFlpb2M2YmI3V0dpS3BJS3ZaS0RQWFhWb1Z5dzhjUWV2emVuRk81UGxoLTRuS2l3Y1hRa1NOREFyNERiN2NmN1dQdEd1UHZVQko1U1ltbXM2aWppdTBtQ09mWW5DaVdKUVZMalhrc0ZXR19NUXY5WE…
Nomura Holdings, Inc. 2027 Q1 - Results - Earnings Call Presentation (NYSE:NMR) 2026-07-29 - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxOdXI5dklNVTZGOGVRVVZ0SlpFbDQ4bk9TckFFam11Q05TeUN4OHVJVHVXVk1acHR0eHc2bldNTkNvbHVLNDZJdXhEa2JQN1NxT1lJeWtNNzl6WHB4bHdLMWlSM00xeVBKOHowQllHRVZ1MzB3V3lMaU9YMS1KOEVsNFp6b3d3bW96LUlQNH…
NMR — Frequently Asked Questions
What is the current share price of NMR?
As of 2026-08-05 17:25 PDT, NMR trades at $9.93 on NASDAQ/NYSE. Its 52-week range is $6.73 to $10.04.
What is the market capitalisation of NMR?
NMR has a market capitalisation of $30.67B on NASDAQ/NYSE.
What is the P/E ratio of NMR?
NMR trades at a trailing price-to-earnings (P/E) ratio of 0.08. Its price-to-book (P/B) ratio is 0.01.
What is the return on equity (ROE) of NMR?
NMR has a return on equity (ROE) of 9.77%.
Is NMR a good stock to buy?
This page provides a data-driven analysis of NMR, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.